275.53 USD
+2.33 (+0.85%)
275.53 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 70% to CME. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 289.08. This target is 4.92% above the current price.
CME was analyzed by 21 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about CME.
In the previous month the buy percentage consensus was at a similar level.
CME was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-12 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-23 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-23 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2025-10-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-25 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-09-25 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-09-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-24 | UBS | Downgrade | Buy -> Neutral |
| 2025-07-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-24 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-10 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-06-04 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-25 | UBS | Maintains | Buy -> Buy |
| 2025-04-24 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-04-24 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-04-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-23 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-03 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2025-04-02 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-03-10 | Raymond James | Upgrade | Market Perform -> Outperform |
CME GROUP INC / CME FAQ
What is the average price target for CME GROUP INC (CME) stock?
21 analysts have analysed CME and the average price target is 289.08 USD. This implies a price increase of 4.92% is expected in the next year compared to the current price of 275.53.
Can you provide the consensus rating for CME GROUP INC stock?
The consensus rating for CME GROUP INC (CME) is 69.5238 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed CME GROUP INC (CME)?
The number of analysts covering CME GROUP INC (CME) is 21.